Preferential localization of effector memory cells in nonlymphoid tissue.

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol (2003) 11.48

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci U S A (2002) 8.72

Adaptive immune features of natural killer cells. Nature (2009) 8.46

Memory CD8 T-cell differentiation during viral infection. J Virol (2004) 6.75

Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol (2009) 6.62

Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity (2007) 6.48

Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat Immunol (2005) 5.83

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med (2002) 5.64

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov (2010) 5.55

Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50

Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med (2004) 5.08

Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci U S A (2004) 4.93

Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity (2007) 4.92

Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature (2012) 4.64

CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev (2006) 4.49

Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity (2003) 4.49

Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol (2012) 4.44

Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest (2001) 4.37

Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity (2008) 4.25

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med (2003) 4.20

Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med (2001) 4.17

Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest (2003) 4.14

Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Med (2010) 4.09

CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature (2009) 4.03

Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med (2003) 3.86

Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med (2001) 3.75

Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci U S A (2010) 3.68

The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol (2013) 3.53

Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci U S A (2001) 3.51

Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity (2013) 3.51

Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity (2010) 3.49

Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature (2011) 3.38

Diversity in T cell memory: an embarrassment of riches. Immunity (2009) 3.31

CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med (2002) 3.28

Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol (2010) 3.26

Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity (2012) 3.21

Dendritic cells maximize the memory CD8 T cell response to infection. Immunity (2005) 3.21

Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med (2003) 3.20

Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load. Immunity (2011) 3.19

Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol (2009) 3.19

Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med (2007) 3.09

Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol (2009) 3.09

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood (2004) 3.05

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol (2008) 3.04

A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity (2005) 3.02

Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J Exp Med (2005) 3.02

The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med (2009) 2.82

Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype. J Exp Med (2006) 2.80

Sensing and alarm function of resident memory CD8⁺ T cells. Nat Immunol (2013) 2.79

Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Immunol (2012) 2.70

Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol (2010) 2.66

Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U S A (2012) 2.64

Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci U S A (2007) 2.62

LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest (2007) 2.57

Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat Immunol (2014) 2.52

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza. Immunol Rev (2006) 2.49

FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol (2009) 2.49

The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol (2011) 2.46

NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med (2006) 2.45

The integration of T cell migration, differentiation and function. Nat Rev Immunol (2013) 2.42

Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol (2013) 2.40

Differential contributions of central and effector memory T cells to recall responses. J Exp Med (2005) 2.40

Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J Immunol (2008) 2.35

Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol (2009) 2.31

Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat Immunol (2013) 2.30

Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance. Cell (2015) 2.28

Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol (2002) 2.28

Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest (2004) 2.25

Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat Immunol (2013) 2.23

Regional and mucosal memory T cells. Nat Immunol (2011) 2.21

Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol (2013) 2.19

T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. J Exp Med (2001) 2.16

Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J Exp Med (2011) 2.16

Differential T cell function and fate in lymph node and nonlymphoid tissues. J Exp Med (2002) 2.14

Mechanisms maintaining peripheral tolerance. Nat Immunol (2009) 2.14

Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol (2003) 2.14

The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity (2008) 2.13

TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med (2005) 2.12

Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc Natl Acad Sci U S A (2004) 2.08

Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest (2005) 2.07

IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory. Proc Natl Acad Sci U S A (2003) 2.07

Tissue-resident memory T cells. Immunity (2014) 2.04

Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J Exp Med (2002) 2.03

Intravascular staining for discrimination of vascular and tissue leukocytes. Nat Protoc (2014) 2.03

A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs. Proc Natl Acad Sci U S A (2001) 2.03

Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med (2002) 2.02

CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses. Proc Natl Acad Sci U S A (2009) 2.01

Cutting edge: intravascular staining redefines lung CD8 T cell responses. J Immunol (2012) 1.99

CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection. Immunity (2014) 1.98

CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells. J Exp Med (2006) 1.97

An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J Exp Med (2006) 1.94

CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog (2006) 1.93

Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med (2004) 1.89

Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J Exp Med (2003) 1.87

Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev (2010) 1.85

Rapid turnover of effector-memory CD4(+) T cells in healthy humans. J Exp Med (2004) 1.85

Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood (2010) 1.85

Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity (2009) 1.84

E-cadherin promotes accumulation of a unique memory CD8 T-cell population in murine salivary glands. Proc Natl Acad Sci U S A (2011) 1.76

Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection. J Exp Med (2015) 1.75

Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol (2000) 12.81

Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature (1988) 4.89

Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol (2001) 4.38

Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc Natl Acad Sci U S A (1998) 2.29

Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J Immunol (1995) 2.18

N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J Virol (1986) 2.01

Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection. J Immunol (2001) 1.84

Differential expression of the leucocyte-common antigen family. Immunol Today (1988) 1.70

Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity (2000) 1.67

Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59

Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol (1997) 1.56

Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J Immunol (1999) 1.53

Functional modifications of cytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies. Nature (1985) 1.51

Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol (2012) 1.35

Age-dependent intestinal lymphoproliferative disorder due to stem cell factor receptor deficiency: parameters in small and large intestine. J Immunol (1997) 1.34

Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer's patches. J Exp Med (2000) 1.34

Interactions between stem cell factor and c-Kit are required for intestinal immune system homeostasis. Immunity (1994) 1.13

Novel antigenic determinants of the T200 glycoprotein expressed preferentially by activated cytotoxic T lymphocytes. J Immunol (1985) 1.13

Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol (1996) 1.11

T cell receptor-triggered activation of intraepithelial lymphocytes in vitro. Int Immunol (1993) 1.04

The role of IL-7 in thymic and extrathymic development of TCR gamma delta cells. J Immunol (1998) 1.00

Beta2 integrins and ICAM-1 are involved in establishment of the intestinal mucosal T cell compartment. Immunity (1996) 0.98

Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma. Growth Factors (1994) 0.95

Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation. Immunol Cell Biol (1999) 0.89

Prevention of autoimmune diabetes by treatment with anti-LFA-1 and anti-ICAM-1 monoclonal antibodies. Cell Immunol (1994) 0.89

CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol (1997) 0.87

Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy. Cancer Immunol Immunother (1995) 0.86

Selection of intestinal intraepithelial lymphocyte T cell receptors: evidence for a dynamic tissue-specific process. Int Immunol (1993) 0.84

Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J Immunol (1997) 0.83

Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model. Cancer Immunol Immunother (1994) 0.83

Proteolytic degradation of rat growth hormone-releasing factor(1-29) amide in rat pituitary and hypothalamus. Brain Res (1993) 0.82

Novel IL-15 isoforms generated by alternative splicing are expressed in the intestinal epithelium. Genes Immun (2006) 0.82

Ras gene mutations in vinyl chloride-induced liver tumours are carcinogen-specific but vary with cell type and species. Int J Cancer (2000) 0.82

Potential for interferon-alpha-based therapy in mesothelioma: assessment in a murine model. J Interferon Cytokine Res (1995) 0.80

Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells. Diabetes (1995) 0.80

Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein. Eur J Immunol (1981) 0.79

Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma. J Hepatol (2000) 0.78

Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice. J Autoimmun (1997) 0.78

Requirement for extrathymic class I histocompatibility antigens for positive selection of thymus-derived T lymphocytes. J Immunol (1995) 0.78

Glycosyltransferase regulation mediated by pre-TCR signaling in early thymocyte development. Int Immunol (1998) 0.78

Susceptibility to murine experimental autoallergic myasthenia gravis: the role of antibody specificity. Clin Exp Immunol (1986) 0.77

Fibrositis and primary hypothyroidism. J Rheumatol (1988) 0.77

Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor tolerance. Clin Cancer Res (2001) 0.76

Anatomy of T-cell development in the intestine. Gastroenterology (1998) 0.75

Transgenic mouse model of intestine-specific mucosal injury and repair. J Natl Cancer Inst Monogr (2001) 0.75